RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 million. Mountain View, California-based RenovoRx priced more than 11.5 million shares of common stock at $1.05 per share. It expects the proceeds to total approximately $12.1 million before deducting underwriting discounts, … [Read more...] about RenovoRx prices $12.1M offering
RenovoRx
RenovoRx to increase production of RenovoCath catheter delivery system
RenovoRx announced today that it plans to increase the production of its RenovoCath catheter-based delivery system. The Los Altos, California-based company cited increased demand for the delivery of diagnostic and/or therapeutic agents. It signed a new project work order with its principal manufacturing partner, Medical Murray, providing for an … [Read more...] about RenovoRx to increase production of RenovoCath catheter delivery system
RenovoRx wins FDA clearance for RenovoCath delivery system
RenovoRx today said it received FDA 510(k) clearance for its RenovoCath delivery system. Los Altos, California-based RenovoRx designed the RenovoCath system as the device component for its RenovoGem chemotherapy drug. The combined drug/device RenovoTAMP trans-arterial micro-perfusion therapy is a dual-balloon infusion catheter that delivers … [Read more...] about RenovoRx wins FDA clearance for RenovoCath delivery system
